ロード中...
Hemorrhagic pericarditis with cardiac tamponade after percutaneous coronary intervention associated with the use of abciximab
Glycoprotein (GP) IIb/IIIa inhibitors, such as abciximab, are used as adjunctive therapy for percutaneous coronary intervention (PCI) in high-risk non-ST-elevation myocardial infarction (NSTEMI) and in ST-elevation myocardial infarction (STEMI), although their effects when used for STEMI are less cl...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Association of Internal Medicine
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2686964/ https://ncbi.nlm.nih.gov/pubmed/18787370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2008.23.3.156 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|